Advanced search×

Welcome to the Pubget Medical Subject Headings (MeSH) browser.

Click on a topic or subtopic below to explore related papers. You'll find the most recent paper about the current MeSH term along with other related papers below.

All › Therapeutics › Combined Modality Therapy › Chemotherapy, Adjuvant

Chemotherapy, Adjuvant (0)

      Articles on Chemotherapy, Adjuvant

      1. Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival
        Ryan K RK Van Laar

        J Mol Diagn 13(3):8 (2011) PMID 21458382

        Gene expression analysis is a valuable tool for determining the risk of disease recurrence and overall survival of an individual patient with breast cancer. The purpose of this study was to create and validate a robust prognostic algorithm and implement it within an online analysis e...
        View PDF
      2. Odontogenic Carcinosarcoma: Case Report and Literature Review
        Ruwadzano Chikosi, Norberto Segall, ... Paul Freedman

        J Oral Maxillofac Surg 69(5):7 (2011) PMID 21195529

      3. Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial).
        Susanne S Ziefle, Friederike F Egberts, ... Martin M Schaefer

        J Immunother 34(4):403-8 (2011) PMID 21499123

        We evaluated HRQoL using the European Organization for Research and Treatment of Cancer Quality of Life Core 30 questionnaire at baseline and after 3, 6, and 12 months of IFN-α treatment in 282 patients. Nine of 15 subscales showed significant poorer results after 3 months of adjuvant IFN treatment...
      4. Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma.
        Avo A Artinyan, Daniel A DA Anaya, ... Joseph J Kim

        Cancer 117(10):2044-9 (2011) PMID 21089103

        Neoadjuvant therapy has been used to improve survival in operable pancreatic cancer. The authors' objective was to compare long-term outcomes in patients receiving neoadjuvant versus adjuvant therapy for resectable pancreatic adenocarcinoma.
      5. [Growth hormone receptor antagonist in the treatment of acromegaly].
        Erika E Hubina, Agnes A Tóth, ... Miklós M Góth

        Orv Hetil 152(18):709-14 (2011) PMID 21498159

        Exploration of construction, function and interaction of human growth hormone and growth hormone receptor in details resulted in the innovation of the new growth hormone receptor antagonist, pegvisomant. Pegvisomant with different mechanism of action extended the tools of medical management of acrome...
      6. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
        Walter W Stummer, Martin J MJ van den Bent, and Manfred M Westphal

        Acta Neurochir (Wien) 153(6):1211-8 (2011) PMID 21479583

        This article discusses data from 3 randomized phase 3 trials, supporting a role for surgery in glioblastoma.
      7. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.
        Daniel G Haller, Josep Tabernero, ... Hans-Joachim Schmoll

        J Clin Oncol 29(11):1465-71 (2011) PMID 21383294

        This multicenter, randomized trial compared capecitabine plus oxaliplatin (XELOX) with bolus fluorouracil (FU) and folinic acid (FA) as adjuvant therapy for patients with stage III colon cancer. Patients who had undergone curative resection were randomly assigned to X...
      8. Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive...
        Jeffrey M Albert, Ana M Gonzalez-Angulo, ... Thomas A Buchholz

        Cancer 117(8):1595-601 (2011) PMID 21472707

        Estrogen receptor (ER) and progesterone receptor (PR) are important prognostic and predictive biomarkers in breast cancer. Patients with tumors positive for either receptor are generally considered hormone receptor-positive for treatment decisions. However, some data suggest that patients with ER(+)...
      9. Cetuximab in the treatment of squamous cell carcinoma of the head and neck.
        Specenier P and Vermorken JB

        Expert Rev Anti Infect Ther 11(4):511-24 (2011) PMID 21504318

        The majority of the head and neck cancers are squamous cell carcinomas, which commonly overexpress the EGF receptor (EGFR). Cetuximab is a chimeric monoclonal antibody that binds with high affinity to the extracellular domain of EGFR, and in addition induces antibody-dependent cellul...
      10. Clear-cell renal carcinoma metastasis to the base of the tongue and sphenoid sinus: Two very rare atypical ENT locations
        J-B Morvan, J-B Veyrières, ... P Verdalle

        Eur Ann Otorhinolaryngol Head Neck Dis 128(2):4 (2011) PMID 21195689

        We report two rare locations: the base of the tongue, and the sphenoid sinus. First-line treatment is surgical, due to low radiosensitivity, with radiation therapy as a possible second line. Functional impact is a prime issue, to avoid functional mutilation. Such meta...